公开(公告)号：US20240131033A1

公开(公告)日：2024-04-25

申请号：US18277718

申请日：2022-02-04

申请人： ASTON UNIVERSITY

发明人： Roslyn Mary Bill ,  Stuart David Greenhill ,  Luke David Southan

IPC分类号： A61K31/5415 ,  A61K31/46 ,  A61P25/00

CPC分类号： A61K31/5415 ,  A61K31/46 ,  A61P25/00

摘要： This invention relates to a method of treating damage to the central nervous system, comprising administering a pharmaceutically-effective amount of a CCR5 antagonist, and a pharmaceutically effective amount of an AQP4 antagonist, or pharmaceutically acceptable salts thereof.

公开(公告)号：US20240226108A9

公开(公告)日：2024-07-11

申请号：US18277718

申请日：2022-02-04

申请人： ASTON UNIVERSITY

发明人： Roslyn Mary Bill ,  Stuart David Greenhill ,  Luke David Southan

IPC分类号： A61K31/5415 ,  A61K31/46 ,  A61P25/00

CPC分类号： A61K31/5415 ,  A61K31/46 ,  A61P25/00

摘要： This invention relates to a method of treating damage to the central nervous system, comprising administering a pharmaceutically-effective amount of a CCR5 antagonist, and a pharmaceutically effective amount of an AQP4 antagonist, or pharmaceutically acceptable salts thereof.